{"id":10325,"date":"2025-07-21T15:45:29","date_gmt":"2025-07-21T13:45:29","guid":{"rendered":"https:\/\/syva.es\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/"},"modified":"2025-07-21T17:01:40","modified_gmt":"2025-07-21T15:01:40","slug":"le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe","status":"publish","type":"post","link":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/","title":{"rendered":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe"},"content":{"rendered":"<h3><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syvazul\u00ae BTV 3 a re\u00e7u une opinion favorable du CVMP pour une administration \u00e0 la dose de 2 mL chez les bovins.<\/span><\/h3>\n<p><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Le\u00f3n, le 21 juillet 2025 <\/span><\/strong> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">\u2013 Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9<\/span> <strong><a class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-underline text-strikethrough-none\" draggable=\"false\" href=\"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-committee-veterinary-medicinal-products-cvmp-15-17-july-2025\" target=\"_blank\" rel=\"noopener\">une opinion positive<\/a><\/strong>,<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">La variation principale <strong>est l<\/strong><\/span>\u2019<strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml<\/span><\/strong>,<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> <strong>ce <\/strong>qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">L\u2019indication propos\u00e9e est l\u2019immunisation active des bovins afin de r\u00e9duire la vir\u00e9mie caus\u00e9e par le s\u00e9rotype 3 de la fi\u00e8vre catarrhale ovine, selon un sch\u00e9ma vaccinal <\/span><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">de deux injections intramusculaires de 2 ml administr\u00e9es \u00e0 trois semaines d\u2019intervalle.<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syvazul\u00ae BTV 3 est actuellement autoris\u00e9 pour l\u2019immunisation active des<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> ovins<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">afin de r\u00e9duire la vir\u00e9mie, la mortalit\u00e9, les signes cliniques et les l\u00e9sions caus\u00e9s par le s\u00e9rotype 3 de la fi\u00e8vre catarrhale ovine, selon un sch\u00e9ma vaccinal<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>d\u2019une injection sous-cutan\u00e9e de 2 ml \u00e0 partir de l\u2019\u00e2ge de 3 mois.<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Syva se complace en anunciar que el 17 de julio de 2025, el Comit\u00e9 de Medicamentos de Uso Veterinario (CVMP) adopt\u00f3 una opini\u00f3n positiva, recomendando la aprobaci\u00f3n de una variaci\u00f3n de las condiciones de la autorizaci\u00f3n de comercializaci\u00f3n de la vacuna Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.<\/p>\n","protected":false},"author":4,"featured_media":10321,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[2177,794,792,444,806],"tags":[2215,2243,2331,2242,2374,2146,2126],"class_list":["post-10325","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communique-de-presse","category-en-bref","category-entreprise","category-non-classifiee","category-syva-dans-le-monde","tag-bovins","tag-btv3-fr","tag-europe-fr","tag-fco-fievre-catarrhale-ovine","tag-opinion-positive","tag-sante-animale","tag-vaccin"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva<\/title>\n<meta name=\"description\" content=\"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva\" \/>\n<meta property=\"og:description\" content=\"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"Syva\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-21T13:45:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-21T15:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION-1110x624.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1110\" \/>\n\t<meta property=\"og:image:height\" content=\"624\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Caroline De Siron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline De Siron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\"},\"author\":{\"name\":\"Caroline De Siron\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\"},\"headline\":\"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe\",\"datePublished\":\"2025-07-21T13:45:29+00:00\",\"dateModified\":\"2025-07-21T15:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\"},\"wordCount\":217,\"publisher\":{\"@id\":\"https:\/\/syva.es\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"keywords\":[\"Bovins\",\"BTV3\",\"Europe\",\"FCO - fi\u00e8vre catarrhale ovine\",\"opinion positive\",\"Sant\u00e9 animale\",\"vaccin\"],\"articleSection\":[\"Communiqu\u00e9 de Presse\",\"En bref\",\"Entreprise\",\"Non classifi\u00e9(e)\",\"Syva dans le monde\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\",\"url\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\",\"name\":\"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"datePublished\":\"2025-07-21T13:45:29+00:00\",\"dateModified\":\"2025-07-21T15:01:40+00:00\",\"description\":\"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.\",\"breadcrumb\":{\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/syva.es\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/syva.es\/fr\/#website\",\"url\":\"https:\/\/syva.es\/fr\/\",\"name\":\"Syva\",\"description\":\"Soluciones con sentido para la salud animal\",\"publisher\":{\"@id\":\"https:\/\/syva.es\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/syva.es\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/syva.es\/fr\/#organization\",\"name\":\"Syva\",\"url\":\"https:\/\/syva.es\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Syva\"},\"image\":{\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\",\"name\":\"Caroline De Siron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/syva.es\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"caption\":\"Caroline De Siron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva","description":"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/","og_locale":"fr_FR","og_type":"article","og_title":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva","og_description":"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.","og_url":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/","og_site_name":"Syva","article_published_time":"2025-07-21T13:45:29+00:00","article_modified_time":"2025-07-21T15:01:40+00:00","og_image":[{"width":1110,"height":624,"url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION-1110x624.png","type":"image\/png"}],"author":"Caroline De Siron","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Caroline De Siron","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#article","isPartOf":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/"},"author":{"name":"Caroline De Siron","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052"},"headline":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe","datePublished":"2025-07-21T13:45:29+00:00","dateModified":"2025-07-21T15:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/"},"wordCount":217,"publisher":{"@id":"https:\/\/syva.es\/fr\/#organization"},"image":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","keywords":["Bovins","BTV3","Europe","FCO - fi\u00e8vre catarrhale ovine","opinion positive","Sant\u00e9 animale","vaccin"],"articleSection":["Communiqu\u00e9 de Presse","En bref","Entreprise","Non classifi\u00e9(e)","Syva dans le monde"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/","url":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/","name":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe - Syva","isPartOf":{"@id":"https:\/\/syva.es\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage"},"image":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","datePublished":"2025-07-21T13:45:29+00:00","dateModified":"2025-07-21T15:01:40+00:00","description":"Syva a le plaisir d\u2019annoncer que le 17 juillet 2025, le Comit\u00e9 des m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire (CVMP) a adopt\u00e9 une opinion favorable, recommandant l\u2019approbation d\u2019une variation des conditions de l\u2019autorisation de mise sur le march\u00e9 du vaccin Syvazul\u00ae BTV 3. La variation principale est l\u2019inclusion de l\u2019esp\u00e8ce bovine \u00e0 la dose de 2 ml, ce qui am\u00e9liore la praticit\u00e9 et s\u2019aligne sur les donn\u00e9es r\u00e9glementaires les plus r\u00e9centes.","breadcrumb":{"@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#primaryimage","url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/syva.es\/fr\/le-cvmp-emet-une-opinion-positive-pour-syvazul-btv3-en-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/syva.es\/fr\/"},{"@type":"ListItem","position":2,"name":"Le CVMP \u00e9met une opinion positive pour Syvazul\u00ae BTV3 en Europe"}]},{"@type":"WebSite","@id":"https:\/\/syva.es\/fr\/#website","url":"https:\/\/syva.es\/fr\/","name":"Syva","description":"Soluciones con sentido para la salud animal","publisher":{"@id":"https:\/\/syva.es\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/syva.es\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/syva.es\/fr\/#organization","name":"Syva","url":"https:\/\/syva.es\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","width":512,"height":512,"caption":"Syva"},"image":{"@id":"https:\/\/syva.es\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052","name":"Caroline De Siron","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/syva.es\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","caption":"Caroline De Siron"}}]}},"modified_by":null,"_links":{"self":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/comments?post=10325"}],"version-history":[{"count":1,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10325\/revisions"}],"predecessor-version":[{"id":10330,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/posts\/10325\/revisions\/10330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/media\/10321"}],"wp:attachment":[{"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/media?parent=10325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/categories?post=10325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/syva.es\/fr\/wp-json\/wp\/v2\/tags?post=10325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}